Won HH et al. – The current results indicated that a genome–wide pharmacogenomic approach is useful for identifying novel polymorphism predictors of severe oxaliplatin–induced chronic peripheral neuropathy (OXCPN) that may be used in personalized chemotherapy. [more...]
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close